BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 271966)

  • 1. Oligopeptides as potential antiaggregation agents for deoxyhemoglobin S.
    Kubota S; Yang JT
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5431-4. PubMed ID: 271966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sickle hemoglobin gelation by amino acids and related compounds.
    Noguchi CT; Schechter AN
    Biochemistry; 1978 Dec; 17(25):5455-9. PubMed ID: 728408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory effect of alkylureas and alkylamides on the gelation of hemoglobin S.
    Herskovits TT; Elbaum D
    Biochim Biophys Acta; 1980 Mar; 622(1):36-51. PubMed ID: 7362836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptides as inhibitors of the gelation of sickle hemoglobin.
    Noguchi CT; Luskey KL; Pavone V
    Mol Pharmacol; 1985 Jul; 28(1):40-4. PubMed ID: 4021996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NH2-terminal region of the sickle hemoglobin beta chain. II. Characterization of monospecific antibodies.
    Young NS; Eastlake A; Schechter AN
    J Biol Chem; 1976 Oct; 251(20):6431-8. PubMed ID: 977582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical modifications that inhibit gelation of sickle hemoglobin.
    Benesch R; Benesch RE; Yung S
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1504-5. PubMed ID: 4524653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NH2-terminal region of the beta chain of sickle hemoglobin. I. Synthesis and purification of oligopeptides.
    Eastlake A; Curd JG; Schechter AN
    J Biol Chem; 1976 Oct; 251(20):6426-30. PubMed ID: 977581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of phenylalanine derivatives on the solubility of deoxyhemoglobin S. A model class of gelation inhibitors.
    Noguchi CT; Ackerman S; DiMaio J; Schiller PW; Schechter AN
    Mol Pharmacol; 1983 Jan; 23(1):100-3. PubMed ID: 6865893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncovalent modification of deoxyhemoglobin S solubility and erythrocyte sickling.
    Waterman MR; Yamaoka K; Dahm L; Taylor J; Cottam GL
    Proc Natl Acad Sci U S A; 1974 Jun; 71(6):2222-5. PubMed ID: 4526343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleation-controlled aggregation of deoxyhemoglobin S. Participation of hemoglobin A in the aggregation of deoxyhemoglobin S in concentrated phosphate buffer.
    Adachi K; Ozguc M; Asakura T
    J Biol Chem; 1980 Apr; 255(7):3092-9. PubMed ID: 7358731
    [No Abstract]   [Full Text] [Related]  

  • 11. Peptide inhibitors of sickle hemoglobin aggregation: effect of hydrophobicity.
    Gorecki M; Votano JR; Rich A
    Biochemistry; 1980 Apr; 19(8):1564-8. PubMed ID: 7378365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxyhemoglobin S gelation and insolubility at high ionic strength are distinct phenomena.
    Roth EF; Bookchin RM; Nagel RL
    J Lab Clin Med; 1979 May; 93(5):867-71. PubMed ID: 429878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton longitudinal relaxation investigation of histidyl residues of normal human adult and sickle deoxyhemoglobin: evidence for the existence of pregelation aggregates in sickle deoxyhemoglobin solutions.
    Russu IM; Ho C
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6577-81. PubMed ID: 6256747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kinetics of the sol-gel transformation of deoxyhemoglobin S by continuous monitoring of viscosity.
    Harris JW; Bensusan HB
    J Lab Clin Med; 1975 Oct; 86(4):564-75. PubMed ID: 1176810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative aspirins as antisickling agents: acetyl-3,5-dibromosalicylic acid.
    Walder JA; Zaugg RH; Iwaoka RS; Watkin WG; Klotz IM
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5499-503. PubMed ID: 271972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of the polymerization of hemoglobin in high and low phosphate buffers.
    Adachi K; Asakura T
    Blood Cells; 1982; 8(2):213-24. PubMed ID: 6186320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of red cell membrane on the polymerization of sickle hemoglobin.
    Goldberg MA; Lalos AT; Himmelstein B; Bunn HF
    Blood Cells; 1982; 8(2):237-43. PubMed ID: 7159748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mimics of the binding sites of opioid receptors obtained by molecular imprinting of enkephalin and morphine.
    Andersson LI; Müller R; Vlatakis G; Mosbach K
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4788-92. PubMed ID: 7761401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S.
    Nagel RL; Bookchin RM; Johnson J; Labie D; Wajcman H; Isaac-Sodeye WA; Honig GR; Schilirò G; Crookston JH; Matsutomo K
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):670-2. PubMed ID: 284392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleation-controlled aggregation of deoxyhemoglobin S. Possible difference in the size of nuclei in different phosphate concentrations.
    Adachi K; Asakura T
    J Biol Chem; 1979 Aug; 254(16):7765-71. PubMed ID: 468786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.